ORAMED PHARMACEUTICALS INC. Total Liabilities
ORAMED PHARMACEUTICALS INC. (ORMP) had Total Liabilities of $502.69 thousand as of 2012-05-31, per its 10-Q filed 2012-07-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2012-07-12
- 2012-05-31: Liabilities $502.69K.
- 2012-02-29: Liabilities $744.14K.
- 2011-08-31: Liabilities $602.02K.
| Period end | Liabilities |
|---|---|
| 2012-05-31 | $502.69K 10-Q · filed 2012-07-12 |
| 2012-02-29 | $744.14K 10-Q · filed 2012-04-04 |
| 2011-08-31 | $602.02K 10-Q · filed 2012-07-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |